PT-141 10mg

PT-141 (Bremelanotide)

Available at 10mg, is a synthetic research peptide commonly investigated in laboratory studies involving melanocortin receptor research, MC3R/MC4R pharmacology, and peptide-receptor binding studies.

Supplied as a high-purity lyophilised peptide powder, this compound is intended strictly for controlled in-vitro research applications alongside our broader range of research peptides UK laboratories rely on. Every batch supplied by Imperial Peptide UK undergoes independent third-party analytical testing, including HPLC purity verification, identity confirmation, heavy metal screening, and endotoxin analysis. Batch-specific Certificates of Analysis (CoAs) are provided to support analytical verification, laboratory traceability, and research documentation standards.

Specifications

• SKU: PT14110
• Form: Lyophilised peptide powder
• Purity: Typically ≥99%
• Appearance: White lyophilised powder
• Storage: Store at -20°C
• After reconstitution: Store at 2–8°C

Chemical Information

• Molecular Formula: C50H68N14O9
• Molecular Weight: 1025.24 g/mol
• CAS Number: 189691-06-3

Research Applications

PT-141 (Bremelanotide) is a synthetic cyclic peptide derived from MT-2, studied in laboratory settings for melanocortin receptor interactions, specifically MC3R and MC4R binding pharmacology. Researchers include PT-141 in in-vitro studies examining melanocortin system signalling, receptor selectivity, and cyclic peptide structure-activity relationships.

⚠ Safety & Legal Notice

This product is supplied strictly for in-vitro laboratory research use only. It is not intended for human or veterinary use, consumption, administration, or clinical application. The purchaser is responsible for ensuring compliance with all applicable laws and regulations relating to the handling and use of research materials.